Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia.
about
Size-dependent ferrohydrodynamic relaxometry of magnetic particle imaging tracers in different environmentsTherapeutic mechanism of treating SMMC-7721 liver cancer cells with magnetic fluid hyperthermia using Fe₂O₃ nanoparticles.Highly Stable Amine Functionalized Iron Oxide Nanoparticles Designed for Magnetic Particle Imaging (MPI).Antitumor magnetic hyperthermia induced by RGD-functionalized Fe3O4 nanoparticles, in an experimental model of colorectal liver metastasesMagnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy.Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.Targeted hyperthermia after selective embolization with ferromagnetic nanoparticles in a VX2 rabbit liver tumor model.Physical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through Néelian and Brownian relaxation: a review.Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria.Self-consistent magnetic properties of magnetite tracers optimized for magnetic particle imaging measured by ac susceptometry, magnetorelaxometry and magnetic particle spectroscopy.Iron oxide-loaded hollow mesoporous silica nanocapsules for controlled drug release and hyperthermia.Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia.DNA-capped Fe3O4/SiO2 magnetic mesoporous silica nanoparticles for potential controlled drug release and hyperthermiaLarge scale production of biocompatible magnetite nanocrystals with high saturation magnetization values through green aqueous synthesisMagnetic Fluid Hyperthermia of Rodent Tumors Using Manganese Perovskite Nanoparticles
P2860
Q30435802-216B5D09-743B-4725-B419-8AC73C2A9D29Q34502603-FAB80615-15CD-472E-A586-529B32905946Q34788751-E6E7DA11-3103-4CAA-AF28-85B58178FCBAQ37587874-864291C6-CE3D-480E-8A9C-4B7C73E9F7E5Q38094012-104ACD8A-6F99-4DE4-8035-443DF8504476Q38494691-E3821F6C-C3B6-4BCD-B3E0-9F2A9D3FFB52Q39079207-3F4662EC-ED0A-4BCC-8CC5-C798CCA71A31Q39196839-43B3742F-ED4C-4073-A47C-381E6536170AQ42559026-DCB5605E-3CFE-4F4B-9121-50981F85D033Q43160472-E6F99D9D-75B5-471E-AE4B-A0704CFCD7C3Q46736494-6CBA583F-6392-45A2-86FB-1925D59A5758Q46749921-C06F0CC6-CBE5-43C4-95F8-D95FCF7367C4Q57366339-6DD90067-80C2-47DF-93FF-F94DE2D5D68BQ57696814-3F7B9F81-071E-4097-B48B-EFAA803C0E1DQ59059741-2DC7282D-E34C-4DE6-BBD7-B07D49B1987D
P2860
Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia.
@en
Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia.
@nl
type
label
Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia.
@en
Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia.
@nl
prefLabel
Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia.
@en
Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia.
@nl
P2093
P2860
P356
P1476
Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia
@en
P2093
Julian A Simon
Kannan M Krishnan
R Matthew Ferguson
P2860
P304
7B306-7B3063
P356
10.1063/1.3671427
P577
2012-02-13T00:00:00Z